ABSTRACT
INTRODUCTION
Breast cancer is the most common cancer among Egyptian women representing 18.9% of total cancer cases (1) of its high incidence (2) , with a rate more than twice that of colorectal cancer and cervical cancer The contribution of inflammation and inflammatory cells to the process of tumor progression is being recognized (4) . Several reports have elaborated the involvement of chemokines in tumor growth, invasion and metastasis 
RANTES
(regulated upon activation normal T-cells expressed and secreted) belongs to a family of CC chemokine (6) , generated by circulatory lymphocytes and certain kinds of tissue cell monocytes (7) . It is a potent chemoattractant for various important inflammatory cells such as esinophils (8) , memory T cells, monocytes and basophiles (9) . RANTES is thought to play an important role in a variety of disease states including allergic inflammatory diseases as asthma, allergic rhinitis and atopic dermatitis (10) through their ability to cause direct migration of leucocytes (11) . RANTES is the major determinant of macrophage and lymphocyte infiltration in the carcinomas of the breast, ovary and cervix (12) which has a potential role in breast cancer progression (13) . IL-8 is a member of the CXC chemokine family of related proinflammatory cytokines, it acts as a chemoattractant for neutrophils (14&15) . It is considered as an angiogenic chemokine, (16) , as it bears glutamic acid, leucine, arginine positive motif (17) and it is secreted by stromal cells (18) . A tumor promoting role for IL-8 has been proposed in a wide variety of human solid tumors including breast cancer (19) . The aim of the current work is to estimate levels of RANTES and IL-8 in breast cancer patients with and without distant metastasis and to correlate their levels in liver and other organ metastasis with those without metastasis and healthy controls.
SUBJECTS & METHODS
The study was carried out on 70 females, they were divided into 3 groups:- There is a significant increase in group A on comparing to the control group and also in group B compared to the control group, while there is no significant difference between group A and group B regarding RANTES. On the other hand, IL-8 shows a significant increase in group A on comparing to the control group and in group B when compared to the control group, and also between group B and group A. There was no significant difference among group B with liver metastasis, with liver and other organ metastasis and with other organ metastasis regarding RANTES and IL-8. The mean value of IL-8 among those with liver metastasis is significantly higher than those without liver metastasis, while RANTES shows no significant difference. The mean value of IL-8 between those with LN metastasis is significantly higher than those without LN metastasis, while RANTES shows no significant difference.
RESULTS

DISCUSSION
Breast cancer is the second leading cause of cancer deaths in women world-wide (23) , members of the chemokine family have been observed to contribute to both growth and progression of different types of human cancers (24) . The aim of the present work was to estimate levels of RANTES and IL-8 in breast cancer patients with and without distant metastasis and to correlate their levels in liver and other organ metastasis with those without metastasis and healthy controls.
The present study showed that there was a significant increase in the level of IL-8 in serum of breast cancer patients without metastasis when compared to the controls and a highly significant increase in breast cancer patients with metastasis was found when compared to the control. Also, a significant increase was noted in metastatic group when compared to non metastatic group. (30&31) also showed a strong correlation between the metastatic potential of breast carcinoma cell lines and their ectopic expression of IL-8 and showed that increased IL-8 expression in metastatic prone cell lines is possibly caused by atypical epigenetics, whereby upstream CPG methylation rather than promoter methylation results in increased IL-8 production.
Razmkhah et al., (32) , found that IGF-1 and IL-8 RNA in breast cancer tissues had 28.6 and 56 fold more expression in high stage compared to low stage patients respectively.
Chen et al., (15) found that estrogen receptor beta (ER beta ) and PEA3 play an important role in tumor invasion by positive regulation of ER beta and PEA3-IL-8 pathway.
Vegran et al., (16) found that the lactate/NF-kappa B-IL-8 pathway is an important link between tumor metabolism and angiogenesis.
The current study showed that there was no significant difference between liver, liver with other organ metastasis and other organ metastasis in breast cancer patients with metastasis regarding IL-8, while there was a significant increase in patients with liver metastasis when compared to those without liver metastasis and also in patients with loco regional LN metastasis when compared to patients with no loco regional LN metastasis.
These results correlated with Benoy et al., (20) who explained that the increase of IL-8 in liver metastasis might be due to decrease clearance of IL-8 by liver cells and metastatic tumor cells continue to produce IL-8, and explained that the increase in nodal metastasis speculate that IL-8 contribute to early metastasis.
Regarding RANTES, the present study found a significant increase in breast cancer patients without metastasis when compared to the control group, and a highly significant increase in breast cancer patients with metastasis when compared to the control group, while there was no significant difference between metastatic and non metastatic groups. On the other hand, Niwa et al.,
reported a significant increase in RANTES level in breast cancer patients when compared with the control group and also reported a highly significant increase in metastatic group when compared to non metastatic group.
The current study showed that, there was no significant difference between liver, liver with other organ metastasis and other organ metastasis in breast cancer patients group with metastasis and also no significant difference was found on comparing patients with liver and loco regional LN metastasis when compared with those without liver and loco regional LN metastasis respectively. These results are matched with 
